Company news
MedMira Inc. news in 2023
MedMira Inc.'s news releases, calls and decks from 2023, newest first.
MedMira Reports First Quarter Results FY2024
December 29, 2023
U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
December 13, 2023
MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
November 28, 2023
Update on MedMira's Regulatory Path in Canada and the USA
September 27, 2023
Progress Update on Securities
August 30, 2023
MedMira Reports Third Quarter Results FY2023
June 29, 2023
MedMira Reports Second Quarter Results FY2023
April 3, 2023
Update on MedMira's Reveal TP (Syphilis) Clinical Trials in Canada
March 14, 2023
MedMira enters into Partnership with Maternova for USA and Latin America
February 21, 2023
MedMira Enters into Partnership with Maternova for USA and Latin America
February 20, 2023
MedMira receives CE mark for its VYRA(TM) CoV2Flu Antigen Test
January 11, 2023
Point-of-Care Diagnostic for Trichomonas Vaginalis Based on MedMira's RVF Technology(R)
January 3, 2023